GW501516 is a PPARδ receptor agonist that was invented in a collaboration between Ligand Pharmaceuticals and GlaxoSmithKline in the 1990s, was entered into clinical development as a drug candidate for .
Molar mass: 453.498 g/mol
Formula: C21H18F3NO3S2
PubChem CID: 9803963
ChemSpider ID: 7979723
People also search for: Enobosarm, LGD-4033, Ibutamoren,